Disruption of crosstalk between the fatty acid synthesis and proteasome pathways enhances unfolded protein response signaling and cell death.
Disruption of crosstalk between the fatty acid synthesis and proteasome pathways enhances unfolded protein response signaling and cell death.
复制标题
DOI:
10.1158/1535-7163.mct-08-0558
复制
发表时间:
2008-12
影响因子:
5.7
通讯作者:
Kridel SJ
中科院分区:
文献类型:
--
作者:
Little JL;Wheeler FB;Koumenis C;Kridel SJ
Fatty Acid Synthase (FASN) is the terminal enzyme responsible for fatty acid synthesis and is upregulated in tumors of various origins to facilitate their growth and progression. Because of several reports linking the fatty acid synthase and proteasome pathways, we asked whether FASN inhibitors could combine with bortezomib, the FDA-approved proteasome inhibitor, to amplify cell death. Indeed, bortezomib treatment augmented sub-optimal FASN inhibitor concentrations to reduce clonogenic survival, which was paralleled by an increase in apoptotic markers. Interestingly, FASN inhibitors induced accumulation of ubiquinated proteins and enhanced the effects of bortezomib treatment. In turn, bortezomib increased fatty acid synthesis, suggesting crosstalk between the pathways. We hypothesized that cell death resulting from crosstalk perturbation was mediated by increased unfolded protein response (UPR) signaling. Indeed, disruption of crosstalk activated and saturated the adaptation arm of UPR signaling, including eIF2α phosphorylation, activating transcription factor 4 (ATF4) expression, and X-box binding protein 1 (XBP-1) splicing. Furthermore, while single agents did not activate the alarm phase of the UPR, crosstalk interruption resulted in activated JNK and C-EBP homologous protein (CHOP)-dependent cell death. Combined, the data support the concept that the UPR balance between adaptive to stress signaling can be exploited to mediate increased cell death and suggests novel applications of FASN inhibitors for clinical use.